CollPlant Biotechnologies Ltd. Share Price & Technical Analysis
CLGN · $0.39 (-7.14%)
Healthcare / Biotechnology
$0.39
-7.14%
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal an…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
0% return in May, 21% avg return in past 3 year May month.
-51% return in 2026, -6% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 36% | -67% | 0% | -20% | 0% | – | – | – | – | – | – | – | -51% |
| 25 | 0% | -5% | -26% | -19% | 52% | -55% | 85% | 8% | 4% | -15% | 5% | -36% | -3% |
| 24 | -11% | -2% | 2% | 11% | -5% | -11% | -14% | 26% | -4% | -24% | 25% | -16% | -23% |
| 23 | 32% | 1% | -35% | -3% | 15% | 6% | -20% | 10% | -16% | -2% | 2% | 21% | 10% |
| 22 | -40% | 9% | 4% | -15% | -4% | -13% | -4% | -3% | -8% | -7% | -21% | 65% | -37% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound care product for the treatment of deep surgical incisions and deep wounds. It also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. The company has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$5.57M
P/E ratio
—
52W high
$4.98
52W low
$0.27
Volume
3,097
Beta
0.64
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is CollPlant Biotechnologies Ltd. share price today?
- CollPlant Biotechnologies Ltd. (CLGN) last traded around $0.39 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CLGN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CLGN. Download the app for real-time alerts.
- How can I analyze CollPlant Biotechnologies Ltd. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.